CMMBVSNIVF• 12 Months (Normalized)
CMMB vs NIVF (Chemomab Therapeutics Ltd. vs NewGenIvf Group Limited)
Showing Closing Date Range from Sep 29, 2025 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-36.98%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
NIVF Performance $0.59
+%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin NIVF LEADS
-36.98 pts
NIVF outperforming by 36.98 percentage points
CMMBNIVF
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | CMMB Price | CMMB Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -36.98% | $- | - | |
| Sep 28, 2026 | $1.64 | -38.11% | $- | - | |
| Sep 25, 2026 | $2.16 | -18.49% | $- | - | |
| Sep 24, 2026 | $2.20 | -16.98% | $- | - | |
| Sep 23, 2026 | $2.28 | -13.96% | $0.59 | -99.94% | +85.98% |
| Sep 22, 2026 | $2.51 | -5.28% | $0.73 | -99.92% | +94.64% |
| Sep 21, 2026 | $2.48 | -6.42% | $0.72 | -99.93% | +93.51% |
| Sep 18, 2026 | $2.61 | -1.51% | $0.72 | -99.93% | +98.42% |
| Sep 17, 2026 | $2.80 | +5.66% | $0.72 | -99.93% | +105.59% |
| Sep 16, 2026 | $2.65 | +0.00% | $0.79 | -99.92% | +99.92% |
| Sep 15, 2026 | $2.47 | -6.79% | $0.84 | -99.91% | +93.12% |
| Sep 14, 2026 | $2.45 | -7.55% | $0.93 | -99.90% | +92.35% |
| Sep 11, 2026 | $2.58 | -2.64% | $1.06 | -99.89% | +97.25% |
| Sep 10, 2026 | $2.60 | -1.89% | $1.11 | -99.89% | +98.00% |
| Sep 09, 2026 | $2.69 | +1.51% | $1.10 | -99.89% | +101.40% |
Page 1 of 17